Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of melatonin on inflammatory markers and pain after elective laparoscopic cholecystectomy
IRCT20250814066851N1Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in postoperative pain and post-operative inflammation, sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Change in inflammatory factors and Postoperative pain intensity. Started Oct 2025; status: completed.
02
Drugs
melatonin
03
Conditions
postoperative painpost-operative inflammation
Beyond the preview
Go deeper on IRCT20250814066851N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250814066851N1.